PD-1/PD-L1 immune checkpoint inhibitors are successfully used in treatments for many types of cancer types (43, 44), but autoimmune diseases such as autoimmune thyroiditis occur from time to time. This evidence concerns the gene PDCD1 and autoimmune thyroid disease.